This webinar has ended. See upcoming webinars. A case-based Novartis-sponsored webinar with retinal surgeons Adrian Fung and Gaurav Bhardwaj on tailoring laser, anti-VEGF, steroid and surgical treatment in proliferative diabetic retinopathy.From Consensus to Clinic: Individualising Laser and Anti-VEGF Decisions in PDR
When
6 pm Brisbane · 6:30 pm Adelaide · 4 pm Perth · 1 hr 30 min
What you’ll learn
- Applying consensus guidance and trial evidence (DRS, DRCR Protocols S and AB, CLARITY) to individual patients
- Cases with and without DMO, vitreous haemorrhage, tractional detachment and neovascular glaucoma
- Systemic factors such as rapid glycaemic control with GLP-1 receptor agonists, adherence and pregnancy
Speakers
Adrian Fung
Head, Vitreoretinal Unit, Westmead Hospital
Vitreoretinal surgeon and medical retina specialist who has led multiple clinical trials, and the first surgeon outside the US to insert the Port Delivery System.
Gaurav Bhardwaj
Ophthalmic Surgeon
Ophthalmic surgeon in vitreoretinal surgery, cataract surgery and medical retina, operating on adults and children, with a PhD on retinal haemorrhages in children.
Hosted by
mivision is the Australian and New Zealand publication for eye care professionals, covering clinical practice, technology and business for optometrists, ophthalmologists and optical dispensers. Its miwebinars program hosts free sponsored clinical webinars with leading ophthalmologists and optometrists, many accredited for RANZCO or Optometry Australia CPD.